Transcripts
Neumora Therapeutics (NMRA) earnings call transcripts
Earnings call transcripts for Neumora Therapeutics, Inc., with a summary, the guidance given, and what analysts pressed on.
- Q4 2025 earnings call
Management framed 2026 around several clinical catalysts, while emphasizing that NMRA 215’s unexpected rat findings delay its path to the clinic.
Date n/aPositive0.48